title: Lipsosomal amphotericin B for treatment of cutaneous leishmaniasis.
authors.affiliation: Infectious Diseases Service, Walter Reed Army Medical Center, Washington, District of Columbia 20307, USA. glenn.wortmann@us.army.mil
authors.forename: Glenn
authors.initials: G
authors.lastname: Wortmann
authors.forename: Michael
authors.initials: M
authors.lastname: Zapor
authors.forename: Roseanne
authors.initials: R
authors.lastname: Ressner
authors.forename: Susan
authors.initials: S
authors.lastname: Fraser
authors.forename: Josh
authors.initials: J
authors.lastname: Hartzell
authors.forename: Joseph
authors.initials: J
authors.lastname: Pierson
authors.forename: Amy
authors.initials: A
authors.lastname: Weintrob
authors.forename: Alan
authors.initials: A
authors.lastname: Magill
mesh_terms: D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016773:Leishmaniasis, Cutaneous / Q000188:drug therapy*; D008081:Liposomes; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000981:Antiprotozoal Agents; D008081:Liposomes; C068538:liposomal amphotericin B; D000666:Amphotericin B